BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Clin Oncol. Nov 24, 2026; 17(11): 122944
Published online Nov 24, 2026. doi: 10.5306/wjco.122944
Comprehensive prognostic value of prealbumin and albumin in hepatocellular carcinoma resection: Insights from a Chinese multicenter cohort
Hao-Xin Shen, Yin-Sen Song, Hui-Feng Wang, Chen Chen, Jin-Kun Song, Chen-Guang Sun, Shu-Zhai Miao, Xin-Guo Chen, Shi-Lei Bai, Yun-Feng Zhao, Kui Wang
Hao-Xin Shen, Yin-Sen Song, Jin-Kun Song, Chen-Guang Sun, Shu-Zhai Miao, Xin-Guo Chen, Yun-Feng Zhao, Organ Transplant Center, The Fifth Clinical Medical College of Henan University of Chinese Medicine/People’s Hospital of Zhengzhou, Zhengzhou 450000, Henan Province, China
Hui-Feng Wang, Department of Hepatobiliary Surgery, The Fifth Clinical Medical College of Henan University of Chinese Medicine/People’s Hospital of Zhengzhou, Zhengzhou 450000, Henan Province, China
Chen Chen, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, Shaanxi Province, China
Shi-Lei Bai, Kui Wang, Department of Hepatic Surgery II, The Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China
Co-first authors: Hao-Xin Shen and Yin-Sen Song.
Co-corresponding authors: Yun-Feng Zhao and Kui Wang.
Author contributions: Shen HX, Song YS, Wang HF, Chen C contributed to conception; Shen HX, Song JK, Sun CG, Miao SZ, Bai SL, Zhao YF, Wang K contributed to study design; Zhao YF, Wang K contributed to administrative support; Shen HX, Song YS, Wang HF, Chen C, Song JK, Sun CG, Miao SZ, Chen XG, Bai SL contributed to data collection and acquisition; Shen HX, Song YS, Wang HF, Bai SL contributed to data analysis; all the authors support the final approval of the manuscript; Zhao YF and Wang K played important and indispensable roles in the manuscript preparation as the co-corresponding authors; Shen HX and Song YS have made crucial and indispensable contributions towards the completion of the project and thus qualified as the co-first authors of the paper.
AI contribution statement: Portions of this manuscript were edited using AI tools solely for language refinement. The authors carefully reviewed and verified all AI-assisted outputs and take full responsibility for the scientific content of the manuscript.
Institutional review board statement: The study was reviewed and approved by the Ethics Committee of Zhengzhou People’s Hospital (No. 2026-ZYLW-009), the Third Affiliated Hospital of Naval Military Medical University, and the First Affiliated Hospital of Xi’an Jiaotong University.
Informed consent statement: All study participants, or their legal guardians, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All authors have no conflicts of interest or disclosure to declare.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement- checklist of items.
Data sharing statement: If necessary, datasets are available from the corresponding author at wangkuiykl@163.com.
Corresponding author: Kui Wang, Academic Fellow, Chief Physician, Full Professor, Department of Hepatic Surgery II, The Eastern Hepatobiliary Surgery Hospital, Shanghai 200433, China. wangkuiykl@163.com
Received: May 7, 2026
Revised: August 12, 2026
Accepted: October 10, 2026
Published online: November 24, 2026
Processing time: 199 Days and 0.1 Hours
Abstract
BACKGROUND

Albumin and prealbumin are established prognostic factors for hepatocellular carcinoma (HCC), but their combined impact on post-resection long-term outcomes requires further clarification.

AIM

To compare the impact of albumin, prealbumin, and their combination on long-term postoperative outcomes in HCC patients.

METHODS

The various impacts of albumin (low < 40 g/L, or normal ≥ 40 g/L) and prealbumin (low < 170 mg/L, or normal ≥ 170 mg/L) on overall survival (OS) and recurrence-free survival (RFS) for HCC patients following partial hepatectomy were comprehensively analyzed using a multi-institutional database.

RESULTS

During a median follow-up of 64.1 months, 892 recurrences and 675 deaths were recorded. Significant differences in OS and RFS were observed across the four groups (all P < 0.001). Compared with Group I (normal albumin and prealbumin), Group II (low albumin, normal prealbumin), Group III (normal albumin, low prealbumin), and Group IV (low albumin and low prealbumin) had shorter OS [Group II: hazard ratio (HR) = 1.37, 95%CI: 1.07-1.76; Group III: HR = 1.89, 95%CI: 1.49-2.39; Group IV: HR = 2.46, 95%CI: 2.02-2.99] and RFS (Group II: HR = 1.25, 95%CI: 1.02-1.54; Group III: HR = 1.65, 95%CI: 1.34-2.02; Group IV: HR = 1.95, 95%CI: 1.64-2.32). Multivariable analysis showed prealbumin was a dominant prognostic predictor for OS and RFS than albumin. When both markers were included, albumin lost independent prognostic value, while low prealbumin (regardless of albumin) remained an independent risk factor for worse OS and RFS. After adjusting for confounders, Group IV had the highest adjusted HR for reduced OS (1.65, 95%CI: 1.34-2.02, P < 0.001) and RFS (1.33, 95%CI: 1.10-1.60, P = 0.002). Time-dependent area under the curve analysis demonstrated that the combined stratification consistently outperformed albumin across all time points (all P < 0.001), with prealbumin showing modestly superior discrimination to albumin.

CONCLUSION

Prealbumin outperforms albumin as a prognostic biomarker for long-term survival after HCC resection. Combining prealbumin and albumin enables precise risk stratification, aiding surgical decision-making and patient counseling. This prealbumin-based risk stratification approach may help optimize perioperative management and identify high-risk patients.

Keywords: Prealbumin; Hepatocellular carcinoma; Hepatectomy; Overall survival; Recurrence-free survival

Core Tip: In this multicenter Chinese cohort of 1550 hepatocellular carcinoma patients undergoing curative resection, prealbumin demonstrated superior prognostic value over albumin for overall survival and recurrence-free survival. When both markers were combined, low prealbumin with normal or low albumin independently predicted worse outcomes, whereas isolated low albumin did not. This dual-marker approach enables precise risk stratification to guide surgical decisions and postoperative management.

Write to the Help Desk